PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
08-Dec-2019 Viracta Announces Positive Phase 1b/2 Data Presented at Oral Presentation on Lead Program for Epstein-Barr Virus (EBV)-associated Relapsed/Refractory Lymphomas at the 2019 American Society of Hematology (ASH) Annual Meeting Viracta Therapeutics, Inc.
08-Dec-2019 Portola Pharmaceuticals Presents New Interim Data from Ongoing Phase 2a Study of its Oral SYK/JAK Inhibitor Cerdulatinib in Heavily Pre-Treated T-Cell Malignancies Portola Pharmaceuticals, Inc.®
08-Dec-2019 New Long-Term Data Continues to Demonstrate Progression-Free Survival and Overall Survival Benefits with VENCLEXTA®/ VENCLYXTO® (venetoclax) Combination in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) AbbVie
08-Dec-2019 New Long-Term Data Continues to Demonstrate Progression-Free Survival and Overall Survival Benefits with VENCLEXTA®/ VENCLYXTO® (venetoclax) Combination in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) AbbVie
07-Dec-2019 Oncopeptides Presents Updated Efficacy and Safety Data from Pivotal Phase 2 HORIZON Study in Patients With RRMM at ASH Annual Meeting 2019 Oncopeptides AB
07-Dec-2019 Janssen to Acquire Investigational Bermekimab from XBiotech Janssen Pharmaceutical Companies of Johnson & Johnson
07-Dec-2019 Janssen to Acquire Investigational Bermekimab from XBiotech Janssen Pharmaceutical Companies of Johnson & Johnson
06-Dec-2019 Grifols presents its latest Alzheimer's clinical trial data Grifols
06-Dec-2019 LPCN INVESTOR ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Lipocine Inc. Bernstein Liebhard LLP
06-Dec-2019 LPCN INVESTOR ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Lipocine Inc. Bernstein Liebhard LLP
06-Dec-2019 Results from the PROTECT VIII Extension Study with Jivi® Published in Haemophilia Bayer
06-Dec-2019 Inland Empire Health Plan (IEHP) Passes CMS Formulary Review IEHP
06-Dec-2019 Onyx Health Celebrate ‘Historic Year’ with New Appointments and Double-Digit Growth Onyx Health
06-Dec-2019 Key Objectives of The Medical Device and In-Vitro Diagnostic Regulations PharmaLex
06-Dec-2019 Genmab Achieves USD 100 Million Sales Milestone in DARZALEX® (daratumumab) Collaboration with Janssen Genmab
06-Dec-2019 Bimekizumab Phase 3 Psoriasis Study Demonstrates Superiority Versus Humira® UCB, Inc.
06-Dec-2019 3DBio Therapeutics Receives FDA Rare Pediatric Disease Designation for AuriNovo(TM) for Ear Reconstruction in Microtia Patients 3DBio Therapeutics
06-Dec-2019 PRC NHC Issues New Policy on Cord Blood Banks, Implementation Rules To Be Provided Global Cord Blood Corporation
06-Dec-2019 Curis Announces Positive Safety, Tolerability and Pharmacokinetic Data in Ongoing Phase 1 Study of Fimepinostat in Combination with Venetoclax Curis, Inc.
06-Dec-2019 Gastric Electrical Stimulators Market Detailed Analytical Overview by 2027 MARKITWIRED